Detalhe da pesquisa
1.
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition.
Exp Dermatol
; 33(1): e14952, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37974545
2.
Home-Use Hyaluronic Acid Jet Injectors: Unreliable and Unsafe.
Dermatol Surg
; 50(1): 62-68, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37815475
3.
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
J Allergy Clin Immunol
; 152(5): 1095-1106, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37574079
4.
Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid.
Exp Dermatol
; 32(5): 632-640, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36704908
5.
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers.
Exp Dermatol
; 32(7): 1028-1041, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37051698
6.
Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world setting.
J Am Acad Dermatol
; 89(4): 677-684, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37116615
7.
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.
J Eur Acad Dermatol Venereol
; 37(9): 1815-1824, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37014287
8.
Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey.
Lasers Med Sci
; 38(1): 250, 2023 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37917309
9.
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Int J Mol Sci
; 24(18)2023 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37762625
10.
Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
J Am Acad Dermatol
; 86(4): 854-862, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33010325
11.
Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.
Clin Exp Dermatol
; 47(9): 1694-1702, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35596520
12.
Clinical endpoints of needle-free jet injector treatment: An in depth understanding of immediate skin responses.
Lasers Surg Med
; 54(5): 693-701, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35067934
13.
Needle-free jet injection-induced small-droplet aerosol formation during intralesional bleomycin therapy.
Lasers Surg Med
; 54(4): 572-579, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34931319
14.
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Br J Clin Pharmacol
; 87(4): 1953-1962, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33025648
15.
Electronic Pneumatic Injection-Assisted Dermal Drug Delivery Visualized by Ex Vivo Confocal Microscopy.
Lasers Surg Med
; 53(1): 141-147, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32515075
16.
Dermal C4d Deposition and Neutrophil Alignment Along the Dermal-Epidermal Junction as a Diagnostic Adjunct for Hypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis) and Underlying Systemic Disease.
Am J Dermatopathol
; 42(6): 399-406, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31436578
17.
Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.
J Am Acad Dermatol
; 80(1): 80-88, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30482392
18.
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
J Am Acad Dermatol
; 90(2): 395-397, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37804933
19.
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.
Acta Derm Venereol
; 98(7): 648-654, 2018 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29405245
20.
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Clin Immunol
; 174: 63-72, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27876460